Ads
related to: immunology
Search results
Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN
Clinical Trials Arena via Yahoo Finance· 7 days agoAt this year’s European Renal Association Congress, positive interim results were presented from...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 2 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
Melanoma skin cancer vaccine being trialled on NHS halves risk of death or relapse
Daily Telegraph· 2 days agoUsing a cutting-edge technology called an AI-immunology platform, researchers were able to design...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 21 hours agoTeva has a decent pipeline of biosimilars, with some being developed in partnership with Alvotech...
The PASC microbiome - Nature Immunology
Nature· 2 days agoDiagnostic tools or biomarkers for the heterogenous post-acute COVID-19 syndrome (PASC; also known as long COVID) are needed. Research now published in Cell Host and Microbe shows that the gut ...
Cell therapy reckoning: How a 'remarkable resolution of lupus' carried CAR-T from cancer to ...
FierceBiotech· 6 days agoThis story is part 3 in a four-part series about cell therapy created by the Fierce Biotech team....
Setting sights on universal protection for flu
Medical Xpress· 5 days agoImmunology and Infectious Disease Researcher and Senior Lecturer Dr. Hillary Vanderven is working against the clock with World Health Organization (WHO)...
Vaccination induces broadly neutralizing antibody precursors to HIV gp41 - Nature Immunology
Nature· 6 days agoSchief and colleagues show that germline-targeting epitope scaffolds can elicit responses from rare broadly neutralizing antibody precursor B cells with predefined binding specificities and genetic features.
Phase III trial shows donidalorsen cuts attack rate in hereditary angioedema
Medical Xpress· 24 hours agoFor patients with hereditary angioedema, donidalorsen reduces the attack rate, according to a study...
Glaxo (GSK) Up 1.6% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 5 days agoExcluding Xevudy sales, revenues in the Specialty Medicines segment were up 19%. Sales grew in HIV, ...
